News

One stock that managed to outmaneuver the various headwinds torturing the markets throughout the year, however, is data ...
Although Alibaba stock looks reasonably priced, Amazon's lower business risk from the U.S.-China tensions gives it the edge ...
Nasdaq shows technical momentum, yet valuation concerns persist. Analysts expect steady EPS growth, but fair value is in the ...
The NASDAQ 100 started to really take off at the end of the month of June, breaking above the massive all-time high near the ...
Shares of CRISPR Therapeutics have risen 9% year to date against the industry ’s 1% decline, as seen in the chart below. The stock has also outperformed the sector and the S&P 500 Index.
According to Russell, this year, 228 companies are being added to the Russell 3000 index. The reconstitution process started on April 30, with Rank Day or the day the index provider evaluated which ...
Caterpillar Inc. CAT shares have gained 9.5% in the past three months, outperforming the manufacturing - construction and mining industry’s 9.2% growth. The Zacks Industrial Products sector and ...
By investing $250 a month into this ETF, you could grow your position in it to $923,000 in 30 years. Further, this investment could produce almost $37,000 in annual dividend income at that value.
CGC Stock Performance and Estimates Shares of Canopy Growth have plunged 44% year to date compared with the industry ’s 6% fall, as seen in the chart below. Image Source: Zacks Investment Research ...
Going by the price/earnings ratio, the company’s shares currently trade at 8.63 on a forward 12-month basis, lower than 15.63 for the industry. The stock also trades below its 5-year mean of 10.25.
June 23, 2025 — 09:22 am EDT Written by Kinjel Shah for Zacks -> The Johnson & Johnson JNJ stock has risen 4.4% in six months, adding more than $15 billion to its market value.
This is compared with the forward 12-month P/E ratios of 18.23X, 10.64X, and 19.22X at which Williams-Sonoma, Ethan Allen and Arhaus are currently trading.